Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05101239 · ClinicalTrials.gov registry record
Acute and Mild TBI Injury in Military and Civilian Population Using Advanced MR Imaging
A clinical trial of Mild Traumatic Brain Injury, sponsored by The Geneva Foundation.
- Active
- Registry status
- 160
- Enrollment target
- 2
- Study locations
NCT05101239: Active study of Mild Traumatic Brain Injury, sponsored by The Geneva Foundation.
NCT05101239 is a study of Mild Traumatic Brain Injury that is active but no longer recruiting, run by The Geneva Foundation. The registered enrollment target is 160 participants, below the 217-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (26% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05101239, a study of Mild Traumatic Brain Injury, is active but no longer recruiting, sponsored by The Geneva Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective longitudinal study of patients with acute mTBI and comparison with chronic mTBI patients and a cohort without history of TBI or none within 5 years of enrollment. The patients will be recruited from the eligible population at military medical centers in the National Capital Region.
Conditions Studied
Interventions
- DEVICE MRI imaging exam
Study Locations (2)
Maryland
- Walter Reed National Military Medical Center - Bethesda
Virginia
- Fort Belvoir Community Hospital - Fort Belvoir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2019-11-08 |
| Est. Completion | 2026-06-30 |
What the registry record for NCT05101239 still lists
NCT05101239 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 217-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which MRI imaging exam is the first listed.
NCT05101239 reports a single indexed study location in Maryland, Virginia.
Frequently Asked Questions
What is clinical trial NCT05101239 about?
NCT05101239 is a clinical study titled "Acute and Mild TBI Injury in Military and Civilian Population Using Advanced MR Imaging". This is a prospective longitudinal study of patients with acute mTBI and comparison with chronic mTBI patients and a cohort without history of TBI or none within 5 years of enrollment. The patients will be recruited from the eligible population at military medical centers in the National Capital Reg...
What is the current status of trial NCT05101239?
This trial is currently active not recruiting. The enrollment target is 160 participants. The study started on 2019-11-08. Estimated completion is 2026-06-30.
What conditions does trial NCT05101239 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury.
What interventions are being tested in trial NCT05101239?
The interventions under investigation include: MRI imaging exam (DEVICE).
Who is sponsoring clinical trial NCT05101239?
This trial is sponsored by The Geneva Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05101239 being conducted?
This trial has 2 study locations across Maryland, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05101239's enrollment target sits among peer trials
160 12th of 43 higher than 30 of 43 other Mild Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Risk Stratification in Children With Concussion
RECRUITING
-
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
RECRUITING · NA
-
Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI